|
C9ORF85 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.503430E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.176110E-03 |
| Normal-vs-Stage2 |
6.742000E-01 |
| Normal-vs-Stage3 |
4.890200E-01 |
| Normal-vs-Stage4 |
3.098600E-01 |
| Stage1-vs-Stage2 |
1.466970E-01 |
| Stage1-vs-Stage3 |
9.981700E-04 |
| Stage1-vs-Stage4 |
9.774700E-04 |
| Stage2-vs-Stage3 |
3.930000E-01 |
| Stage2-vs-Stage4 |
2.817400E-01 |
| Stage3-vs-Stage4 |
7.054800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.085800E-01 |
| Normal-vs-AfricanAmerican |
3.116800E-01 |
| Normal-vs-Asian |
2.181400E-01 |
| Caucasian-vs-AfricanAmerican |
7.048800E-01 |
| Caucasian-vs-Asian |
2.193000E-01 |
| AfricanAmerican-vs-Asian |
3.174400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.193000E-01 |
| Normal-vs-Female |
1.895980E-01 |
| Male-vs-Female |
8.720200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.896630E-01 |
| Normal-vs-Age(41-60Yrs) |
4.992000E-02 |
| Normal-vs-Age(61-80Yrs) |
5.521800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.723790E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.305200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.634000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.353900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.451570E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.411600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.597600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.00499999994486E-06 |
| Normal-vs-Grade 2 |
1.621710E-04 |
| Normal-vs-Grade 3 |
4.946800E-01 |
| Normal-vs-Grade 4 |
1.381840E-01 |
| Grade 1-vs-Grade 2 |
1.090840E-01 |
| Grade 1-vs-Grade 3 |
9.022600E-04 |
| Grade 1-vs-Grade 4 |
2.320200E-03 |
| Grade 2-vs-Grade 3 |
1.75123999999194E-05 |
| Grade 2-vs-Grade 4 |
5.94600000000112E-05 |
| Grade 3-vs-Grade 4 |
2.879800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.9999999999909E-05 |
| Normal-vs-ccB subtype |
4.304000E-01 |
| ccA subtype-vs-ccB subtype |
4.43000000005522E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.991230E-01 |
| Normal-vs-N1 |
2.043000E-01 |
| N0-vs-N1 |
9.025900E-02 |
|
|
